Diatranz Otsuka Ltd. manufactures pharmaceutical products. Its product, DIABECELL, is used to treat type1 diabetes. The company was founded on November 11, 2011 and is headquartered in Auckland, New Zealand.

Layton BioScience

Diabell Co. Ltd. is a private company headquartered in the South Korea. The firm develops, manufactures and markets components for mobile phone and home appliances. It was founded in 1995. Sam-Jong Kim is currently the CEO of the company.

Research Corporation Technologies, Inc. provides investment related services. It operates as technology development company that typically invests in new technology platforms in life sciences, healthcare technology, biomedical, preclinical and clinical-stage therapeutics, devices, drugs, and diagnostics, medical devices, and biotech tools for gene expression and protein production with medical devices. The company was founded in 1987 and is headquartered in Tucson, AZ.

Optipharm provides a biomedical solution that is involved in the development of cell therapy products using animal stem cells. The company was founded in July 2000 as Avicore Biotechnology Research Center and merged with Medipig Korea and Optipharm Solution Center in December 2007, after which it was renamed Optipharm Solution. It entered the veterinary medicine field in April 2008 by acquiring Farmscare, and it was listed on the KOSDAQ in October 2018 after the company's name was changed to its current name Optipharm in September 2012. It is currently involved in the business of animal disease diagnosis, animal medicine, bacteriophage, Medipig, xenogenic organs, VLP vaccines, and so on, and it is expanding into the field of human medicine based on the technology that it has accumulated in the field of animal medicine.

Nanchang Nuohui Pharmaceutical Technology Co., Ltd., established on 2019-04-22, Business scope includes medical research and experimental development;Bioengineering technology development;Information system integration service;Electronic product development;Computer software and hardware technology development,Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

GH Care, Inc. engages in a cellular engineering and biotech company. It focuses on fulfilling a large unmet need in cell, molecular, and regenerative therapy for treatment of diabetes and other autoimmune and neurodegenerative diseases. The company was founded by Gary Harlem and is headquartered in the United States of America.

MandalMed is a privately-held company focused on modulation of glycobiology and innate immunity to develop treatments for organ fibrosis. The initial target is galectin-3, one of a family of carbohydrate binding proteins. The lead product is MM-003, a protein inhibitor of galectin-3, for prevention and reversal of fibrosis after myocardial infarction and in heart failure

Jiangsu Provincial People's Hospital, a subsidiary of Nanjing Medical University, is a company headquartered in Guangzhou, China. The firm operates hospitals.

Anhui Divinity Biological Products Co., Ltd., part of Beijing Dongfang Diwei Biotechnology Co., Ltd., is a Chinese company located in Zhangzhou that engages in pharmaceutical preparations.

The Nanjing General Hospital of People's Liberation Army (NGH; Chinese: 中国人民解放军南京总医院), formerly Nanjing General Hospital of Nanjing Military Command (Chinese: 中国人民解放军南京军区南京总医院), or Nanjing General Hospital, The Military General Hospital, is also known as Jinling Hospital (formally Jinling Hospital of the Medical School of Nanjing University) which used to be Central Hospital. NGH is located at 305 Zhongshan East Road, Nanjing, Jiangsu Province, China. It is a large comprehensive teaching hospital integrating medical services with teaching and research.

Kookmin University Industry-Academic Cooperation is an independent academic corporation.

PrimeGen Biotech is located in Santa Ana, California and operates a 10,000 sq2. ft facility. The newly renovated facility consists of modern laboratories capable of cell processing, cell culture, molecular biology, flow cytometry, and histology. The laboratories are developed to specifically meet the requirements of our unique research approaches. The PrimeGen team includes research scientists and specialists with many years of experience in basic research of adult stem cells. As PrimeGen Biotech grows, it will remain dedicated to discovering the best possible applications for stem cell therapies and to translate the findings to therapeutic applications.

ZymoGenetics is focused on the discovery, development, and early manufacture of therapeutic proteins. ZymoGenetics is a fully-integrated research and development organization with a broad range of skills and technologies, including scientific computing, molecular and cellular biology, protein chemistry, antibody generation and engineering, clinical development and operations, regulatory affairs, quality, drug formulation, process development and protein manufacturing.

Shenyang Jinghua Hospital Co., Ltd., established on 2017-05-19, Business scope includes licensed projects:medical service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Maternal and infant life care(Does not include medical services),hotel management,Medical Research and Experimental Development,Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion,R&D and application of cell technology(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)